Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Free June 4, 2026 webinar on streamlining precision oncology in community settings. TORONTO, May 13, 2026 /PRNewswire/ -- Most oncology strategies are shaped by evidence and infrastructure built and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results